The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.

The opening celebration of LBI:AD "Gründer Symposium"
With a quite big team of already 14 employees, the LBI Applied Diagnostics decided to be ready to celebrate its inauguration on the 2nd of May 2017. For this occasion,
Johannes Längle - Poster award at the 4th Immunotherapy of Cancer Conference
Johannes Längle from the Division of General Surgery of the Department of Surgery got decorated with a poster award at this year’s 4th Immunotherapy
44. Winterseminar „Biologische Psychiatrie“ Oberlech
From the 18th to the 22nd of March 2017 our director Prof. Dr. Markus Mitterhauser attended the 44. Winter Seminar "Biologische Psychiatrie” in the charming city Oberlech

Share This: